Cimzia Effective With Stable Dosing In Crohn’s Disease
UCB announced today that data presented at Digestive Disease Week reaffirm the long-term, sustainable efficacy and safety of Cimzia (certolizumab pegol) at stable doses in treating patients with...
View ArticleCimzia Risks Linked To Cancer
The TNF blocker known as Cimzia was recently linked to the development of cancerous cells among patients. Cimzia, which treats autoimmune disorders, has been associated with the condition specifically...
View Article
More Pages to Explore .....
